IBDEI0EO ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6705,1,4,0)
 ;;=4^682.6
 ;;^UTILITY(U,$J,358.3,6705,1,5,0)
 ;;=5^Cellulitis Of Leg
 ;;^UTILITY(U,$J,358.3,6705,2)
 ;;=^271894
 ;;^UTILITY(U,$J,358.3,6706,0)
 ;;=682.1^^31^413^8
 ;;^UTILITY(U,$J,358.3,6706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6706,1,4,0)
 ;;=4^682.1
 ;;^UTILITY(U,$J,358.3,6706,1,5,0)
 ;;=5^Cellulitis Of Neck
 ;;^UTILITY(U,$J,358.3,6706,2)
 ;;=^271889
 ;;^UTILITY(U,$J,358.3,6707,0)
 ;;=376.01^^31^413^9
 ;;^UTILITY(U,$J,358.3,6707,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6707,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,6707,1,5,0)
 ;;=5^Cellulitis Of Orbit
 ;;^UTILITY(U,$J,358.3,6707,2)
 ;;=^259068
 ;;^UTILITY(U,$J,358.3,6708,0)
 ;;=681.10^^31^413^12
 ;;^UTILITY(U,$J,358.3,6708,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6708,1,4,0)
 ;;=4^681.10
 ;;^UTILITY(U,$J,358.3,6708,1,5,0)
 ;;=5^Cellulitis, Toe Nos
 ;;^UTILITY(U,$J,358.3,6708,2)
 ;;=^271885
 ;;^UTILITY(U,$J,358.3,6709,0)
 ;;=682.2^^31^413^10
 ;;^UTILITY(U,$J,358.3,6709,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6709,1,4,0)
 ;;=4^682.2
 ;;^UTILITY(U,$J,358.3,6709,1,5,0)
 ;;=5^Cellulitis Of Trunk
 ;;^UTILITY(U,$J,358.3,6709,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,6710,0)
 ;;=070.1^^31^413^27
 ;;^UTILITY(U,$J,358.3,6710,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6710,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,6710,1,5,0)
 ;;=5^Hepatitis A 
 ;;^UTILITY(U,$J,358.3,6710,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,6711,0)
 ;;=070.30^^31^413^28
 ;;^UTILITY(U,$J,358.3,6711,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6711,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,6711,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,6711,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,6712,0)
 ;;=070.32^^31^413^29
 ;;^UTILITY(U,$J,358.3,6712,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6712,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,6712,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,6712,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,6713,0)
 ;;=070.51^^31^413^30
 ;;^UTILITY(U,$J,358.3,6713,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6713,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,6713,1,5,0)
 ;;=5^Hepatitis C Acute
 ;;^UTILITY(U,$J,358.3,6713,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,6714,0)
 ;;=070.54^^31^413^31
 ;;^UTILITY(U,$J,358.3,6714,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6714,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,6714,1,5,0)
 ;;=5^Hepatitis C, Chronic
 ;;^UTILITY(U,$J,358.3,6714,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,6715,0)
 ;;=571.41^^31^413^32
 ;;^UTILITY(U,$J,358.3,6715,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6715,1,4,0)
 ;;=4^571.41
 ;;^UTILITY(U,$J,358.3,6715,1,5,0)
 ;;=5^Hepatitis, Chronic Persist
 ;;^UTILITY(U,$J,358.3,6715,2)
 ;;=^259093
 ;;^UTILITY(U,$J,358.3,6716,0)
 ;;=571.1^^31^413^33
 ;;^UTILITY(U,$J,358.3,6716,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6716,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,6716,1,5,0)
 ;;=5^Hepatitis, ETOH acute
 ;;^UTILITY(U,$J,358.3,6716,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,6717,0)
 ;;=070.59^^31^413^34
 ;;^UTILITY(U,$J,358.3,6717,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6717,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,6717,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,6717,2)
 ;;=Hepatitis, Other Viral^266631
 ;;^UTILITY(U,$J,358.3,6718,0)
 ;;=V08.^^31^413^24
 ;;^UTILITY(U,$J,358.3,6718,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6718,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,6718,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,6718,2)
 ;;=HIV + Status (Asymptomatic)^303392
 ;;^UTILITY(U,$J,358.3,6719,0)
 ;;=042.^^31^413^25
 ;;^UTILITY(U,$J,358.3,6719,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0EO
